abstract |
The following: (i) NHBA antigen; (ii) fHbp antigen; (iii) NadA antigen; (iv) GNA1030 antigen; (v) GNA2091 antigen; (vi) Neisseria meningitidis serogroups A, C, W135, and Y Immunization against Neisseria gonorrhoeae by administering an immunogenic composition comprising one or more of (i) to (v) above in combination with a conjugated capsular saccharide derived from A method of immunizing a subject in need against Neisseria gonorrhoeae. [Selection figure] None |